Amelioration of Hydrolyzed Guar Gum on High-Fat Diet-Induced Obesity: Integrated Hepatic Transcriptome and Metabolome.

Xiaodan Fu,Zhemin Liu,Rong Li,Junyi Yin,Han Sun,Changliang Zhu,Qing Kong,Haijin Mou,Shaoping Nie

DOI: https://doi.org/10.1016/j.carbpol.2022.120051

IF: 10.723

2022-01-01

Carbohydrate Polymers

Abstract:Hydrolyzed guar gum has gained attention as an anti-obesity agent; however, few studies have focused on its role in amelioration of hepatic-associated metabolic processes. Here, the anti-obesity effect of low molecular weight hydrolyzed guar gum (GMLP, 1-10 kDa) on high-fat diet (HFD)-fed C57BL/6 J mice was investigated via transcriptome and metabolome in liver. GMLP reduced body weight gain and hepatic lipid accumulation dose -dependently, regulated blood lipid levels, and improved liver damage in HFD-fed mice. Integrated transcriptome and metabolome indicated that GMLP mainly altered lipid metabolism pathways (glycerophospholipid meta-bolism, glycerolipid metabolism, and fatty acid degradation), reduced disease biomarkers of ethyl glucuronide and neopterin, and increased levels of choline, flavin adenine dinucleotide, and pantetheine metabolites. Real-time quantitative PCR showed that GMLP downregulated key genes involved in de novo lipogenesis and triacylglycerol synthesis, while promoting fatty acid oxidation and choline synthesis. This study provides a theoretical basis for GMLP treatment in future clinical applications.